Terms: = Head and neck cancer AND KEAP1, INrf2, ENSG00000079999, 9817, Q14145, MGC9454, MGC4407, MGC20887, MGC1114, MGC10630, KLHL19, KIAA0132 AND Diagnosis
4 results:
1. PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming.
Ma Y; Zhang X; Han X; Hao Z; Ji R; Li J; Guo W; Zhang Y; Guan F; Ma S
Mol Carcinog; 2023 Jun; 62(6):866-881. PubMed ID: 36988347
[TBL] [Abstract] [Full Text] [Related]
2. Nrf2 and keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
[TBL] [Abstract] [Full Text] [Related]
3. Expression and correlation of NRF2, keap1, NQO-1 and HO-1 in advanced squamous cell carcinoma of the larynx and their association with clinicopathologic features.
Li C; Wu H; Wang S; Zhu J
Mol Med Rep; 2016 Dec; 14(6):5171-5179. PubMed ID: 27840932
[TBL] [Abstract] [Full Text] [Related]
4. Trends in the clinical characteristics of patients with papillary thyroid carcinoma in Taiwan.
Lin JD; Chao TC; Sun JH; Ho C; Weng HF
Oncology; 2000 May; 58(4):280-5. PubMed ID: 10838492
[TBL] [Abstract] [Full Text] [Related]